Phio Pharmaceuticals' Decision to Terminate Share Purchase Agreement with Triton Funds
Friday, 5 July 2024, 12:38
Phio Pharmaceuticals' Termination of Share Purchase Agreement
In a recent announcement, Phio Pharmaceuticals has decided to end its share purchase agreement with Triton Funds LP.
Impact on Stock Market
This move resulted in the cancellation of the potential purchase of up to 18.8% of the company's common stock.
Conclusion: Phio Pharmaceuticals' decision to terminate the agreement has implications for its stock performance and future business strategies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.